Cancer Genetics, Inc. to Present at The MicroCap Conference on October 24-25 in Philadelphia

ARLINGTON, VA / ACCESSWIRE / October 6, 2016 / Cancer Genetics, Inc. (NASDAQ: CGIX) will be presenting at this year’s The MicroCap Conference on October 24-25 in Philadelphia at the Hotel Monaco, along with 60 other companies in the microcap universe.

The MicroCap Conference is an exclusive event for investors who specialize in small and microcap stocks. It is an opportunity to be introduced to and speak with management at some of the most attractive small companies, learn from various expert panels, and mingle with other microcap investors.

If you are a private investor or institutional investor interested in learning more about the conference, please click here.

Investors and interested parties may listen to the live webcast of Cancer Genetics’ presentation on October 25, 2016 at 9:00 am ET by clicking http://wsw.com/webcast/microcapconf2/cgix.

About Cancer Genetics, Inc.

Cancer Genetics Inc. is a leader in enabling precision medicine in oncology from bench to bedside through the use of oncology biomarkers and molecular testing. CGI is developing a global footprint with locations in the US, India and China. We have established strong clinical research collaborations with major cancer centers such as Memorial Sloan Kettering, The Cleveland Clinic, Mayo Clinic, Keck School of Medicine at USC and the National Cancer Institute.

The Company offers a comprehensive range of laboratory services that provide critical genomic and biomarker information. Its state-of-the-art reference labs are CLIA-certified and CAP-accredited in the US and have licensure from several states including New York State.

For more information, please visit or follow CGI at:

Internet: http://www.cancergenetics.com
Twitter: @Cancer_Genetics
Facebook: www.facebook.com/CancerGenetics

SOURCE: Cancer Genetics, Inc.

ReleaseID: 446626